Citations

Showing 10 of 108104 citations.

Mathematical Modeling of Eyebrow Curvature
Tran, Ann Q. , Yang, Cameron, Tooley, Andrea A. , Kazim, Michael, Glass, Lora R. Dagi

Mayo Clinic

Facial Plastic Surgery | February 4, 2022 | Volume: 38 | Issue: 03 | Pages: 307-310

10.1055/s-0041-1742200 | PMID 35114713 Get It

AbstractThe aim of the study is to describe a mathematical model for analyzing eyebrow curvature that can be applied broadly to curvilinear facial features. A total of 100 digital images (50 men, 50 women) were obtained from standardized headshots of medical professionals. Images were analyzed in ImageJ by plotting either 8 or 15 points along the inferior-most row of contiguous brow cilia. A best-fit curve was automatically fit to these points in Microsoft Excel. The second derivative of the second-degree polynomial and a fourth-degree polynomial were used to evaluate brow curvature. Both techniques were subsequently compared with each other. A second-degree polynomial and fourth-degree polynomial were fit to all eyebrows. Plotting 15 points yielded greater goodness-of-fit than plotting 8 points along the inferior brow and allowed for more sensitive measurement of curvature across all images. A fourth-degree polynomial function provided a closer fit to the eyebrow than a second-degree polynomial function. This method provides a simple and reliable tool for quantitative analysis of eyebrow curvature from images. Fifteen-point plots and a fourth-degree polynomial curve provide a greater goodness-of-fit. The authors believe the described technique can be applied to other curvilinear facial features and will facilitate the analysis of standardized images.
Three-Dimensional Technology in Rhinoplasty
Greve, Glynnis De , Malka, Ronit , Barnett, Erica, Robotti, Enrico , Haug, Martin , Lekakis, Garyfalia, Hellings, Peter W. , Hamilton, Grant

Mayo Clinic

Facial Plastic Surgery | February 4, 2022 | Volume: 38 | Issue: 05 | Pages: 483-487

10.1055/s-0041-1741501 | PMID 35114707 Get It

AbstractRhinoplasty is uniquely suited to capitalize on different aspects of three-dimensional (3D) modeling technology. Currently, 3D surface imaging of preoperative and postoperative nasal structure provides a platform for better surgical planning and patient counselling as well as objective postoperative measurements. Physical nasal models using 3D printing technology can improve rhinoplasty performance intraoperatively, postoperative outcomes, together with nasal prosthetic manufacture, by tailoring to specific patient anatomy. Advances in tissue engineering using 3D-printed biocompatible scaffolds have shown excellent nasal cartilage mimicry and hold promise for increasingly versatile directed tissue regeneration in rhinoplasty and nasal reconstructive surgery. As health care innovations are expected to become increasingly common in standard rhinoplasty practices in the future, we give an account of how 3D technologies can create new opportunities to optimize surgical planning and improve overall the patient experience.
Multi‐institutional review of non‐hypospadiac penile urethral stricture management and outcomes
Abramowitz, David , Sam, Andre‐Philippe , Pachorek, Mark, Martins, Francisco E. , Angulo, J.C. , Simhan, Jay , Li, Eric , Policastro, Connor, Ramírez-Pérez, E. A. , Burks, Frank , Shetty, Zubin, Venkatesan, K. , Hunter, Craig, Gallegos, Maxx , Foreman, Jordan , Pariser, Joseph J. , MacDonald, Susan M. , Warner, Jonathan N. , Martins, Francisco , Warner, Jonathan, Ruel, Nora H. , Nikolavsky, Dmitriy , Kasabwala, Khushabu , Lopez, Damian

Mayo Clinic

International Journal of Urology | February 3, 2022 | Volume: 29 | Issue: 5 | Pages: 376-382

10.1111/iju.14786 | PMID 35118726 Get It

Objectives Penile urethral stricture disease not associated with hypospadias is rare, and there is a wide range of commonly used surgical repair techniques for this disease. We sought to compile a multi‐institutional database of patients who had surgical correction of strictures in the penile urethra not limited to the meatus, and who had no history of hypospadias, for analysis using the Trauma and Urologic Reconstructive Network of Surgeons length, urethral segment and etiology classification system. Methods A retrospective database from 13 institutions was compiled of patients who had undergone surgical correction of Trauma and Urologic Reconstructive Network of Surgeons length, urethral segment and etiology urethral stricture segments S2b/S2c and excluding E5, with a minimum follow‐up time of 4 months. Failure was defined as cystoscopically confirmed recurrence of a stricture measuring less than 16‐Fr. Results We analyzed 222 patients with a median age of 57 years and a follow‐up of 49 months. The overall surgical success rate was 80.2%. On multivariate analysis, the two variables identified that were predictive of surgical success were stricture length ≤2 cm as well as use of a buccal mucosa graft as compared to use of a fasciocutaneous flap, which had success rates of 83% and 52%, respectively ( P = 0.0004). No statistically significant differences were found based on incisional approach or surgical technique, nor were outcomes different based on etiology or preoperative patient demographics. Conclusions Surgical repair of penile urethral strictures of non‐hypospadiac origin have a favorable overall success rate, at 80.2%. Regardless of incisional approach or surgical technique, all operations appear to have similar outcomes other than repairs using fasciocutaneous flap, which were statistically less successful than those using buccal mucosa graft.
Research Goes Red: Early Experience With a Participant-Centric Registry
Gilchrist, Susan C. , Hall, Jennifer L. , Khandelwal, Abha , Hidalgo, Bertha , Kinzy, Claire, Mallya, Pratheek , Conners, Katie, Stevens, Laura , Alger, Heather M. , Wexler, Laura, Mega, Jessica L. , Mieres, Jennifer H. , Roger, Véronique L. , Stevens, Laura M , Alger, Heather M , Mehta, Laxmi , Hernandez, Adrian , Hayes, Sharonne N , Jessup, Mariell , Roger, Veronique L , Hall, Jennifer L , Aggarwal, Brooke , Mehta, Laxmi S. , Hernandez, Adrian F. , Hayes, Sharonne N.

Mayo Clinic

Circulation Research | February 3, 2022 | Volume: 130 | Issue: 3 | Pages: 343-351

10.1161/circresaha.121.320403 | PMID 35113661 Get It

Rationale: Cardiovascular disease remains the leading cause of death in women. To address its determinants including persisting cardiovascular risk factors amplified by sex and race inequities, novel personalized approaches are needed grounded in the engagement of participants in research and prevention. Objective: To report on a participant-centric and personalized dynamic registry designed to address persistent gaps in understanding and managing cardiovascular disease in women. Methods and Results: The American Heart Association and Verily launched the Research Goes Red registry (RGR) in 2019, as an online research platform available to consenting individuals over the age of 18 years in the United States. RGR aims to bring participants and researchers together to expand knowledge by collecting data and providing an open-source longitudinal dynamic registry for conducting research studies. As of July 2021, 15 350 individuals have engaged with RGR. Mean age of participants was 48.0 48.0±0.2 years with a majority identifying as female and either non-Hispanic White (75.7%) or Black (10.5%). In addition to 6 targeted health surveys, RGR has deployed 2 American Heart Association-sponsored prospective clinical studies based on participants’ areas of interest. The first study focuses on perimenopausal weight gain, developed in response to a health concerns survey. The second study is designed to test the use of social media campaigns to increase awareness and participation in cardiovascular disease research among underrepresented millennial women. Conclusions: RGR is a novel online participant-centric platform that has successfully engaged women and provided critical data on women’s heart health to guide research. Priorities for the growth of RGR are centered on increasing reach and diversity of participants, and engaging researchers to work within their communities to leverage the platform to address knowledge gaps and improve women’s health.
Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Technical Review
Wanrooij, Roy L.J. van , Bronswijk, Michiel , Kunda, Rastislav , Rimbaș, Mihai , Hucl, Tomáš , Badaoui, Abdenor , Law, Ryan , Arcidiacono, Paolo Giorgio , Giovannini, Marc , Khashab, Mouen A., Binmoeller, Kenneth F., Hooft, Jeanin E. van , Merwe, Van der , van Wanrooij, Roy L J , Rimbas, Mihai , Barthet, Marc , Perez-Miranda, Manuel , van Hooft, Jeanin E , Arcidiacono, Paolo Giorgio , Everett, Simon M , Lakhtakia, Sundeep , Larghi, Alberto , Khashab, Mouen A. , Pérez‐Miranda, Manuel

Mayo Clinic

Endoscopy | February 3, 2022 | Volume: 54 | Issue: 03 | Pages: 310-332

10.1055/a-1738-6780 | PMID 35114696 Get It

Main Recommendations 1 ESGE recommends a prolonged course of a prophylactic broad-spectrum antibiotic in patients with ascites who are undergoing therapeutic endoscopic ultrasound (EUS) procedures.Strong recommendation, low quality evidence. 2 ESGE recommends placement of partially or fully covered self-expandable metal stents during EUS-guided hepaticogastrostomy for biliary drainage in malignant disease.Strong recommendation, moderate quality evidence. 3 ESGE recommends EUS-guided pancreatic duct (PD) drainage should only be performed in high volume expert centers, owing to the complexity of this technique and the high risk of adverse events.Strong recommendation, low quality evidence. 4 ESGE recommends a stepwise approach to EUS-guided PD drainage in patients with favorable anatomy, starting with rendezvous-assisted endoscopic retrograde pancreatography (RV-ERP), followed by antegrade or transmural drainage only when RV-ERP fails or is not feasible.Strong recommendation, low quality evidence. 5 ESGE suggests performing transduodenal EUS-guided gallbladder drainage with a lumen-apposing metal stent (LAMS), rather than using the transgastric route, as this may reduce the risk of stent dysfunction.Weak recommendation, low quality evidence. 6 ESGE recommends using saline instillation for small-bowel distension during EUS-guided gastroenterostomy.Strong recommendation, low quality evidence. 7 ESGE recommends the use of saline instillation with a 19G needle and an electrocautery-enhanced LAMS for EUS-directed transgastric endoscopic retrograde cholangiopancreatography (EDGE) procedures.Strong recommendation, low quality evidence. 8 ESGE recommends the use of either 15- or 20-mm LAMSs for EDGE, with a preference for 20-mm LAMSs when considering a same-session ERCP.Strong recommendation, low quality evidence.
Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and SARS-CoV-2–Related Hospitalizations: A Statewide Report From the Minnesota Electronic Health Record Consortium
Drawz, Paul E. , DeSilva, Malini B. , Bodurtha, Peter , Vazquez‐Benitez, Gabriela , Murray, Anne M. , Dudley, R. Adams , Waring, Stephen C. , Murphy, Daniel , Muscoplat, Miriam Halstead, Meléndez, Victor, McFarling, Lynn, Lupu, Roxana , Johnson, Steve , Johnson, Steven G. , Waring, Stephen C. , Drawz, Paul , Chamberlain, Alanna M. , Kharbanda, Anupam B. , Murphy, Daniel, Melendez, Victor, Margolis, Karen L. , Winkelman, Tyler N A

Mayo Clinic

Clinical Infectious Diseases | February 3, 2022 | Volume: 75 | Issue: 5 | Pages: 890-892

10.1093/cid/ciac110 | PMID 35137021 Get It

Abstract Using vaccine data combined with electronic health records, we report that mRNA boosters provide greater protection than a 2-dose regimen against SARS-CoV-2 infection and related hospitalizations. The benefit of a booster was more evident in the elderly and those with comorbidities.
Postoperative Urinary Incontinence in Diabetic Patients Undergoing Pelvic Reconstructive Surgery
Siddique, Moiuri, Ringel, Nancy E., Winter, K. Lauren de, Marczak, Tara, Kisby, Cassandra, Rutledge, Emily, Soriano, Alex, Samimi, Parisa, Schroeder, Michelle, Handler, Stephanie, Chou, Jiling, Gutman, Robert E., Kisby, Cassandra K. , Siddique, Moiuri, Ringel, Nancy E., Winter, K. Lauren de, Marczak, Tara, Rutledge, Emily, Soriano, Alex, Samimi, Parisa, Schroeder, Michelle, Handler, Stephanie, Chou, Jiling, Gutman, Robert E.

Mayo Clinic

Female Pelvic Medicine & Reconstructive Surgery | February 3, 2022 | Volume: 28 | Issue: 6 | Pages: 372-378

10.1097/spv.0000000000001137 | PMID 35113049 Get It

Importance Diabetes is an independent risk factor for urinary incontinence, and its impact on rates of postoperative incontinence after pelvic reconstructive surgery remains unexplored. Objective The aim of the study was to compare the incidence of postoperative stress urinary incontinence (SUI), urgency urinary incontinence (UUI), and mixed urinary incontinence in patients with diabetes mellitus undergoing surgery for pelvic organ prolapse (POP) with or without SUI surgery. Study Design This is a secondary analysis of a multicenter retrospective cohort study involving 10 diverse medical centers that identified a cohort of women with diabetes who had prolapse and/or anti-incontinence surgery. We compared rates of postoperative urinary incontinence among patients who had surgery for prolapse and incontinence versus surgery for prolapse only. Results Three hundred five patients had surgery for prolapse and incontinence, 330 had surgery for prolapse only, and 189 had anti-incontinence surgery only. De novo UUI was higher among those who underwent surgery for POP and SUI compared with surgery for POP alone (26.4% vs 14.1%, P < 0.01). Rates of persistent SUI (21% vs 4.9%, P < 0.01) and mixed urinary incontinence (15.9% vs 2.7%, P < 0.01) were higher for those who underwent prolapse surgery alone versus prolapse and an incontinence procedure. No differences were seen in hemoglobin A 1C levels between those who did and did not report postoperative UI. Conclusions We found that postoperative de novo UUI rates were high among patients with diabetes after pelvic reconstructive surgery, with the incidence being significantly higher for those who had surgery for prolapse and incontinence compared with surgery for prolapse only.
Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration
Kantarci, Kejal , Nedelská, Zuzana , Chen, Qin , Gunter, Jeffrey L. , Przybelski, Scott A. , Lesnick, Timothy G. , Kremers, Walter K. , Fields, Julie A. , Graff‐Radford, Jonathan , Savica, Rodolfo , Lowe, Val J. , Graff‐Radford, Neill R. , Murray, Melissa M., Reichard, R. Ross , Jack, Clifford R. , Petersen, Ronald C. , Ferman, Tanis J. , Graff-Radford, Jonathan , Botha, Hugo , Dickson, Dennis W , Jack, Clifford R , Boeve, Brad , Nedelska, Zuzana , Kantarci, Kejal , Ferman, Tanis J , Kremers, Walter K , Senjem, Matthew L. , Schwarz, Christopher G. , Jones, David T. , Botha, Hugo , Knopman, David S. , Dickson, Dennis W. , Boeve, Bradley F.

Mayo Clinic

Brain Communications | February 3, 2022 | Volume: 4 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcac013 | PMID 35415608 Get It

Abstract Mild cognitive impairment with the core clinical features of dementia with Lewy bodies is recognized as a prodromal stage of dementia with Lewy bodies. Although grey matter atrophy has been demonstrated in prodromal dementia with Lewy bodies, longitudinal rates of atrophy during progression to probable dementia with Lewy bodies are unknown. We investigated the regional patterns of cross-sectional and longitudinal rates of grey matter atrophy in prodromal dementia with Lewy bodies, including those who progressed to probable dementia with Lewy bodies. Patients with mild cognitive impairment with at least one core clinical feature of dementia with Lewy bodies (mean age = 70.5; 95% male), who were enrolled in the Mayo Clinic Alzheimer’s Disease Research Center and followed for at least two clinical evaluations and MRI examinations, were included (n = 56). A cognitively unimpaired control group (n = 112) was matched 2:1 to the patients with mild cognitive impairment by age and sex. Patients either remained stable (n = 28) or progressed to probable dementia with Lewy bodies (n = 28) during a similar follow-up period and pathologic confirmation was available in a subset of cases (n = 18). Cross-sectional and longitudinal rates of grey matter atrophy were assessed using voxel-based and atlas-based region of interest analyses. At baseline, prodromal dementia with Lewy bodies was characterized by atrophy in the nucleus basalis of Meynert both in those who remained stable and those who progressed to probable dementia with Lewy bodies (P &lt; 0.05 false discovery rate corrected). Increase in longitudinal grey matter atrophy rates were widespread, with greatest rates of atrophy observed in the enthorhinal and parahippocampal cortices, temporoparietal association cortices, thalamus and the basal ganglia, in mild cognitive impairment patients who progressed to probable dementia with Lewy bodies at follow-up (P &lt; 0.05 false discovery rate corrected). Rates of inferior temporal atrophy were associated with greater rates of worsening on the clinical dementia rating–sum of boxes. Seventeen of the 18 (94%) autopsied cases had Lewy body disease. Results show that atrophy in the nucleus basalis of Meynert is a feature of prodromal dementia with Lewy bodies regardless of proximity to progression to probable dementia with Lewy bodies. Longitudinally, grey matter atrophy progresses in regions with significant cholinergic innervation, in alignment with clinical disease progression, with widespread and accelerated rates of atrophy in patients who progress to probable dementia with Lewy bodies. Given the prominent neurodegeneration in the cholinergic system, patients with prodromal dementia with Lewy bodies may be candidates for cholinesterase inhibitor treatment.
SARS‐CoV‐2‐related and Covid‐19 vaccine‐induced thromboembolic events: A comparative review
Afshar, Zeinab Mohseni , Barary, Mohammad , Hosseinzadeh, Rezvan , Alijanpour, Amirmasoud , Miri, Seyed Rouhollah , Carson‐Chahhoud, Kristin , Länger, Florian, Ebrahimpour, Soheil , Barary, Mohammad , Carson-Chahhoud, Kristin , Alijanpour, Amirmasoud , Babazadeh, Arefeh , Sio, Terence T. , Sullman, Mark J. M.

Mayo Clinic

Reviews in Medical Virology | February 3, 2022 | Volume: 32 | Issue: 4 | Pages: No page available

10.1002/rmv.2327 | PMID 35112763 Get It

AbstractSince the start of the pandemic, thrombotic events have been a well‐known and severe complication associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Nevertheless, the initiation of vaccination programs brought another rare yet highly fatal thrombotic event, vaccine‐induced immune thrombotic thrombocytopaenia, which has caused extensive debate regarding the safety of vaccines. This review defines the thromboembolic events following infection and vaccination, identifies their risk factors, describes their pathophysiology, and discusses their management, treatment, and prevention.
Abstract WP58: Telestroke Assessment Of Acute Monocular Visual Loss Fails To Routinely Diagnose Retinal Artery Occlusion And Recommend Thrombolytic Therapy
Dumitrascu, Oana M. , Harahsheh, Ehab , Pahl, Emily, O'Caroll, Cumara, Demaerschalk, Bart M.

Mayo Clinic

Stroke | February 3, 2022 | Volume: 53 | Issue: Suppl_1 | Pages: No page available

10.1161/str.53.suppl_1.wp58 Get It

Introduction: Central retinal artery occlusion (CRAO) is a neurovascular emergency and acute monocular visual loss should trigger a stroke code activation. As thrombolytic therapy is considered for non-arteritic CRAO in the stroke therapeutic window, we aimed to review all telestroke encounters for acute visual loss in Mayo Clinic national telestroke network, focusing on the ocular diagnosis and the management recommendations. Hypothesis: patients evaluated via telestroke for acute visual loss are less likely to receive thrombolysis Methods: We conducted a retrospective review of the Mayo Clinic Arizona Telestroke/Teleneurology (2010-2017, 6364 encounters) and Mayo Clinic Enterprise Telestroke databases (2018-2020, 3147 encounters), searching for visits requested for acute visual loss. We recorded the subjects’ demographics, time from last seen normal to telestroke evaluation, preliminary diagnosis, and therapeutic/diagnostic recommendation. Results: From a total of 9511 audio-video telestroke encounters, 49 (0.51%) had an ocular diagnosis. Out of those, 6 patients (12.2%) had a provisional diagnosis of CRAO. 4/6 (66.6%) CRAO patients presented within 4.5h from symptom onset (median 2 hours) and none received thrombolytic therapy. All telestroke physicians recommended antiplatelet, ophthalmology consultation for diagnostic evaluation and comprehensive stroke work-up. Conclusions: Telestroke evaluations for CRAO, in routine practice, are less common than the disease prevalence would predict, suggesting that education is urgently mandated to increase the index of awareness. Even when CRAO subjects are evaluated via telestroke within 4.5 hours from symptom onset, they do not receive thrombolytic therapy nor timely ophthalmologic evaluation. Telestroke visits may benefit from the inclusion of tele-ophthalmologic consults to help with establishing the diagnosis in the narrow time-window of intravenous thrombolysis.